Institutional shares held 51.8 Million
142K calls
58.4K puts
Total value of holdings $494M
$1.36M calls
$556K puts
Market Cap $521M
56,094,800 Shares Out.
Institutional ownership 92.34%
# of Institutions 185


Latest Institutional Activity in EOLS

Top Purchases

Q2 2025
Bender Robert & Associates Shares Held: 25.1K ($233K)
Q2 2025
Mirae Asset Global Investments Co., Ltd. Shares Held: 2.49K ($23.1K)
Q1 2025
Nuveen, LLC Shares Held: 1.02M ($9.51M)
Q1 2025
Frontier Capital Management CO LLC Shares Held: 1.21M ($11.2M)
Q1 2025
Divisadero Street Capital Management, LP Shares Held: 721K ($6.69M)

Top Sells

Q2 2025
Assenagon Asset Management S.A. Shares Held: 612K ($5.68M)
Q2 2025
Ifp Advisors, Inc Shares Held: 4.41K ($40.9K)
Q2 2025
Gamma Investing LLC Shares Held: 455 ($4.22K)
Q2 2025
Cwm, LLC Shares Held: 184 ($1.71K)
Q2 2025
Massmutual Trust CO Fsb Shares Held: 144 ($1.34K)

About EOLS

Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorporated in 2012 and is headquartered in Newport Beach, California.


Insider Transactions at EOLS

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
237K Shares
From 11 Insiders
Grant, award, or other acquisition 217K shares
Open market or private purchase 20K shares
Sell / Disposition
341K Shares
From 5 Insiders
Open market or private sale 341K shares

Track Institutional and Insider Activities on EOLS

Follow Evolus, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EOLS shares.

Notify only if
Any

Insider Trading

Get notified when an Evolus, Inc. insider buys or sells EOLS shares.

Notify only if
Any
Any
P - Open market or private purchase×
S - Open market or private sale×
V - Transaction voluntarily reported earlier than required×
A - Grant, award, or other acquisition×
D - Sale (or disposition) back to the issuer×
F - Payment of exercise price or tax liability×
I - Discretionary transaction×
M - Exercise of conversion of derivative security×
C - Conversion of derivative security×
E - Expiration of short derivative position×
H - Expiration (or cancellation) of long derivative position with value received×
O - Exercise of out-of-the-money derivative securities×
X - Exercise of in-the-money or at-the-money derivatives securities×
G - Bona fide gift×
L - Small Acquisition×
W - Acquisition or disposition by will or laws×
Z - Deposit into or withdrawal from voting trust×
J - Other acquisition or disposition×
K - Transaction in equity swap or similar instrument×
U - Disposition due to a tender of shares in a change of control transaction×
20 item(s) selected

News

Receive news related to Evolus, Inc.

Track Activities on EOLS